Epalrestat

• Target:

  Reductase

• Related Pathways:

  Endocrinology/Hormones|||Metabolism

• Purity:

  0.9954

• Bioactivity:

  Epalrestat (ONO2235), an aldose reductase inhibitor, is well tolerated in Long-term therapy. It can effectually ameliorate the associated symptoms of diabetic neuropathy and delay the progression of the disease, particularly in patients with limited microangiopathy and good glycemic control.

• Smiles:

  CC (=C/C1=CC=CC=C1) \C=C1/SC (=S) N (CC (O) =O) C1=O

• Molecular Formula:

  C15H13NO3S2

• Molecular Weight:

  319.4

• Shipping Conditions:

  Cool pack

• Storage Temperature:

  -20°C

• CAS Number:

  82159-09-9